Zantac Articles
First Approval For GW's Ranitidine Bismuth Citrate
24 July 1995
European STOCK COMMENT
24 July 1995
Real Threat To Glaxo's Zantac Patent Is Possible
24 July 1995
EUROPEAN STOCK COMMENT
17 July 1995
US Sales of Generic Drugs Up 29% In 1994, Says IMS
17 July 1995
Glaxo Wellcome Slashes Price Of Zantac
10 July 1995
The Drug Industry And The Nafta Experience
10 July 1995
SB's Tagamet: OTC Approval In USA
26 June 1995
TOKYO STOCK COMMENT
26 June 1995
Glaxo Wellcome Patent Battles Continue
19 June 1995
Advice On Where Best Buys In Drugs Are Found
19 June 1995
Ciba Pushing To Market Generic Zantac Pre-1997
12 June 1995
FDA Rules Against Generics On GATT
5 June 1995
European stock comment
5 June 1995
Disease ManagementThe Way Forward
15 May 1995
Gastrointestinals Top Taiwan Market
8 May 1995
WTO Oversight "Will Cost US Consumers"
8 May 1995
European Stock Comment
17 April 1995
German Self-Medication Market Expands
17 April 1995
Oral Imitrex Approvable In USA
10 April 1995
Losec Europe's Top-Selling Product
10 April 1995
20 Leading US Drugs' Price Increases Slammed
27 March 1995
Generic Drugs In Japan
13 March 1995
Spain-Based Fake Drug Business Revealed
13 March 1995
Dutch Govt Has Mistaken Impression Of Drug Prices
13 March 1995
Patent Challenge For Zantac In UK
6 March 1995
Glaxo Interim Profits Up 10% On 2% Sales Rise
13 February 1995
Glaxo, Wellcome Product Lines Are Complementary
6 February 1995
Glaxo Wellcome: Consolidatory But No Panacea
30 January 1995
Glaxo Bids L8.9 Billion To Take Over Wellcome
30 January 1995
Cimetidine Offers Cancer Survival Benefit
23 January 1995
European Stock Comment
16 January 1995
Zantac Gains First OTC Approval
16 January 1995
IMS Studies US Retail Drug Payments
16 January 1995
European Stock Comment
9 January 1995
Japanese Resignation At Glaxo
9 January 1995
$25 Bill Latin American Pharma Market In 2000
9 January 1995
Drug Cos Benefit From GATT Patent Provisions
2 January 1995
US Zantac Patent To Be Extended
2 January 1995
Glaxo Files For Ranitidine Bismuth Citrate Approval
2 January 1995
European Stock Comment
19 December 1994
Losec For GERD Maintenance In USA
12 December 1994
New US Indication For Zantac
28 November 1994
Glaxo Files For OTC Zantac In USA
21 November 1994
Zantac Approved For Eradication Therapy In UK
21 November 1994
Strong Sales And Profits Growth At Astra
21 November 1994
Novopharm Zantac Challenge Rebuffed
14 November 1994
USA's Top-Selling Drugs In 1993
24 October 1994
DDT's New Global Pharma Market Review 1994
10 October 1994
New Zantac Formulation Launched In Japan
3 October 1994
Competition and Acquisition Pressure Hits Glaxo
19 September 1994
Glaxo's Pipeline Update As Expected
19 September 1994
Corporate News In Brief
19 September 1994
New York Stock Comment
19 September 1994
European Stock comment
22 August 1994
Glaxo Rumored To Be Eying Eli Lilly
22 August 1994
Japanese NHI Generics And Substance Patents
22 August 1994
NEW ZANTAC FORMULATION
15 August 1994
TOKYO STOCK COMMENT
1 August 1994
NIPPON GLAXO PROGRAM TO MOVE ZANTAC TO OTC
1 August 1994
The Gloves Are Off In Glaxo/Novopharm Dispute
1 August 1994
Re-Engineering Japanese R&D - Again
25 July 1994
Lilly Buys McKesson's PCS Unit for $4 Billion
18 July 1994
GLAXO CLOSER TO OTC RANITIDINE
11 July 1994
NEGATIVE VIEWS ON GLAXO
27 June 1994
NOVOPHARM FILES ANDA FOR RANITIDINE
27 June 1994
TAIWAN DRUG MARKET IN 1993
13 June 1994
WARNER WELLCOME JV SETS SIGHTS ON TOP SPOT
6 June 1994
FIRST CLINICAL DATA FOR GLAXO'S GR122311X
6 June 1994
EUROPE STOCK COMMENT
23 May 1994
"REVOLUTION" IN EURO OTC DIGESTIVES
23 May 1994
FURTHER DEFENSIVE MOVES FROM SB OVER CIMETIDINE
23 May 1994
EUROPEAN STOCK COMMENT
16 May 1994
EUROPE STOCK COMMENT
9 May 1994
GLAXO TAKES ON GENEVA OVER GENERIC ZANTAC
9 May 1994
EUROPEAN STOCK COMMENT
2 May 1994
EUROPEAN STOCK COMMENT
25 April 1994
LARGE DOWNSIDE FOR GLAXO SHARES
25 April 1994
PROSPECTS FOR DRUG PRICE CHANGES
18 April 1994
EUROPEAN STOCK COMMENT
11 April 1994
EUROPEAN STOCK COMMENT
4 April 1994
FUTURE LOOKS ROSY FOR LOSEC H PYLORI COMBO
4 April 1994
ASTRA'S SHARE PRICE TAKES TEMPORARY DIP
4 April 1994
EUROPEAN STOCK COMMENT
28 March 1994
GENERIC THREAT TO GLAXO'S ZANTAC
28 March 1994
EUROPEAN STOCK COMMENT
14 March 1994
SALES SURGE FOR SOME DRUGS IN ITALY
14 March 1994
UK PRESCRIBING STUDY "WOULD RAISE COSTS"
14 March 1994
THE FUTURE FOR THE US DRUG MARKET
28 February 1994
GYNECOMASTIA WITH ANTIULCERANTS
28 February 1994
SWEDISH PHARMA MARKET GROWTH SLOWDOWN
28 February 1994
GLAXO CONSIDERS OPTIONS FOR USA
28 February 1994
GLAXO SEES 25% INTERIM TRADING PROFIT RISE
21 February 1994
RATIOPHARM CHALLENGES GLAXO
14 February 1994
NIH ISSUES CONSENSUS STATEMENT ON H PYLORI
14 February 1994
UK PRODUCT NEWS IN BRIEF
7 February 1994
GERMAN RANITIDINE PATENT DISPUTE DELAYED
7 February 1994
WINNERS AND LOSERS IN GLOBAL PHARMA INDUSTRY
31 January 1994
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
